Summary & Overview
HCPCS J7307: Etonogestrel Contraceptive Implant System
HCPCS Level II code J7307 covers the supply of an etonogestrel contraceptive implant system, inclusive of the implant device and associated supplies. This code is nationally significant as etonogestrel implants are a widely used long-acting reversible contraceptive option, affecting access, clinical workflows, and payer coverage policies across outpatient reproductive health services. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find an overview of clinical context for implant provision, common settings where the service is delivered, and the practical billing considerations tied to device-inclusive HCPCS billing. The publication outlines typical benchmarks and coverage patterns for device-supply codes, highlights relevant policy updates affecting contraceptive device reimbursement, and explains how this code interacts with service lines such as family planning and outpatient gynecologic care. Practical billing implications, common modifiers used with device-supply claims, and areas where payers differ in coverage or prior-authorization requirements are summarized to inform revenue cycle and clinical leaders. Data not provided in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J7307 represents an etonogestrel (contraceptive) implant system, including implant and supplies. The service type is the provision and placement of a long-acting reversible contraceptive implant system. The typical site of service for this code is outpatient settings where contraceptive implants are supplied and placed, such as ambulatory clinics, family planning clinics, and physicians' offices.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 26-year-old woman presents to an outpatient family planning clinic requesting long-acting reversible contraception. She desires non-daily, highly effective birth control and has no contraindications to progestin-only methods. After counseling, the clinician selects an etonogestrel implant system. On the day of service the patient undergoes insertion of the single-rod etonogestrel implant in the subdermal tissue of the inner upper arm. The clinical workflow includes pre-procedure consent and medical history review, pregnancy testing if indicated, cleansing and local anesthesia of the insertion site, aseptic implant insertion using the manufacturer-supplied applicator and supplies, post-insertion wound care instructions, documentation of device lot and expiration, scheduling of follow-up or removal appointment, and billing of the device and supplies under the appropriate HCPCS code. Typical sites of service are outpatient clinic, physician office, community health center, and family planning clinic. The service type is supply plus device insertion support provided as an outpatient ambulatory procedure. Patient follow-up includes wound check and verification of implant palpability; removal is scheduled per patient preference or at device end-of-use, and removals may require a separate procedure and coding when performed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no special circumstance or modifier applies to the service. |